Glencet film-coated tablets 5 mg 30 pcs.

Active ingredient: levocetirizine;

1 tablet contains levocetirizine dihydrochloride 5 mg;

Excipients: lactose, microcrystalline cellulose, colloidal silicon dioxide, magnesium stearate, Opadry white (Opadry Y 1-7000), titanium dioxide (E 171), polyethylene glycol, hypromellose.

• Hypersensitivity to levocetirizine or to any other component of this dosage form, or to any piperazine derivatives.
• Severe chronic renal failure (creatinine clearance <10 ml/min).
• Rare hereditary diseases of galactose intolerance, lactase deficiency or glucose-galactose malabsorption.

The drug is prescribed to adults and children over 6 years of age orally in a daily dose of 5 mg 1 time per day. Take the tablet regardless of meals. The tablet should be swallowed whole, washed down with a small amount of water.

Pregnant women

Levocetirizine is contraindicated during pregnancy.

Children

The drug in tablet form should not be used in children under 6 years of age, since this dosage form does not allow for the necessary correction of the dosage regimen.

Drivers

You should refrain from driving or operating machinery during the treatment period.

Symptoms of overdose may include drowsiness in adults and initial agitation and increased irritability followed by drowsiness in children.

Treatment. There is no specific antidote for levocetirizine. In case of symptoms of overdose, symptomatic and supportive therapy is recommended. Gastric lavage should be considered shortly after administration. Hemodialysis is not effective in removing levocetirizine from the body.

• From the nervous system: drowsiness, headache, fatigue, weakness, asthenia, convulsions, paresthesias, dizziness, fainting, tremor, dysgeusia.
• Psychiatric: sleep disturbances, agitation, hallucinations, depression, aggression, insomnia, suicidal thoughts.
• Cardiac: tachycardia, tachycardia.
• On the part of the organ of vision: visual impairment, blurred vision.
• From the organs of hearing and balance: vertigo.
• Hepatobiliary disorders: hepatitis.
• Renal and urinary disorders: dysuria, urinary retention.
• Immune system disorders: hypersensitivity, including anaphylaxis.
• Respiratory, thoracic and mediastinal disorders: dyspnea.
• Gastrointestinal: diarrhea, vomiting, constipation, dry mouth, nausea, abdominal pain.
• Skin and subcutaneous tissue disorders: angioedema, persistent drug eruptions, pruritus, rash, urticaria.
• Musculoskeletal, connective tissue and bone disorders: muscle pain.

No interaction studies have been conducted with levocetirizine.

Food intake does not affect the extent of absorption of the drug, but simultaneous ingestion of food reduces the rate of absorption.

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life – 3 years.